Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AA, abide, ABO, absent, accuracy, acre, actuarial, adalimumab, Addendum, addressin, adenocarcinoma, adhered, adherence, adhesion, Adler, ADUVANZ, ADVATE, ADYNOVATE, ADYNOVI, AF, afflicted, Afstyla, ago, aGvHD, Aizenberg, Albert, albumin, ALBUMNAR, ALBUTEIN, Algeria, Alnylam, alpha, Alzheimer, amjevita, analyst, Angiodema, Animal, antigen, Antihemophelic, antihemophilic, antithrombin, antitrypsin, AOCI, AOCL, Apotex, ARALAST, arbitration, artery, asparaginase, aspect, Austria, autoimmune, AWP, bacteria, Bannockburn, BAX, BAXJECT, BDD, belief, bench, biggest, bioavailability, Biochemistry, BioLife, BioOncology, Biosurgery, Biotest, BIVIGAM, BLA, blurry, bond, born, BOS, Bousfiha, BPD, BPL, Brexit, Bribery, bright, Bristol, broaden, bronchopulmonary, Brown, bruising, BUMINATE, Burden, Burlington, burn, burning, busy, bypassing, calaspargase, CALPEG, caption, cardiopulmonary, CARIMUNE, Carolina, Catalyst, cataract, Caterpillar, CEPROTEIN, CEPROTIN, certiorari, Chamber, Chargeback, CHAWI, chemotherapeutic, chimeric, CIDP, Clark, climbed, CLL, Coagil, Coagulant, coagulation, codified, cohort, coinciding, cold, Coli, Commerce, complicated, condensed, conditionally, congenital, constraint, contact, contesting, coronary, costly, counter, Covington, CTI, CUVITRU, cycle, DAC, DBP, DDAVP, Dec, deeper, defect, deleted, deliberated, dementia, demographic, demyelinating, Depomed, Depository, Deschner, desmopressin, devote, digestion, disappointing, disciplinary, disconnect, disgorgement, diversify, divestiture, DME, DOJ, drastically, drop, DSMB, durable, dysplasia, EAFE, EAI, easy, EC, Economist, editing, EHL, Eleison, emphysema, entrepreneurial, environmental, equitable, Erytech, escrow, etanercept, ethical, etrolizumab, Excelsior, expedient, extraordinary, Facteur, factor, fastest, fatty, FEIBA, female, Fenner, Finanziaria, FLEBOGAMMA, FLEXBUMIN, flixabi, Florence, fluctuating, fluorouracil, footprint, Fosler, fractional, fractionation, franchise, freight, frequency, frontrunner, Fuller, fullest, fundamental, fungi, FVIII, Gail, GailFosler, Galaxy, GAMMAGARD, GAMMAKED, GAMMANORM, GAMMAPLEX, gBRCA, gemcitabine, gender, genome, George, GESPP, Gladstone, GLASSIA, globe, Globulin, Globuline, glufosfamide, goal, GRASPA, grey, Grifol, gritty, Halozyme, handed, Hayward, HDN, headline, headquartered, heavy, Helixate, HEMOFIL, hemolytic, hemorrhage, Hexal, hierarchy, HIZENTRA, host, hour, hTTP, HUMIRA, humoral, hurdle, hyaluronidase, hypoalbuminemia, hypogammaglobulinemia, hypovolemia, HYQVIA, Ian, IBD, IG, IGF, IGSC, imalumab, IMMUNINE, immunoglobulin, Immunol, immunomodulator, immunoregulatory, impeded, importantly, imprecise, Imputation, inactivation, incorrect, incredibly, Indenture, inevitable, inflection, inflectra, infuse, infused, infusion, inhibitory, Inline, inside, insight, installment, intake, integrin, interpolation, intravascular, intravenously, intraventricular, invaluable, IP, irinotecan, ISS, iterated, ITP, Ivax, IVH, IX, JAK, Jazz, JNDA, John, journey, Kaketsuken, Kawasaki, KEDBUMIN, Kedrion, Kendall, Kendrion, KIOVIG, Kite, Kogenate, Kovaltry, KPMG, labor, leucovorin, leukemia, leukocyte, LFB, liable, lifelong, lifetime, liposomal, listened, lodged, logic, Los, lot, lung, LV, lymphoblastic, lymphocytic, LYNPARZA, MA, macroeconomic, MAdCAM, maralixibat, MAS, match, matched, maximize, mCRC, meant, Meath, Medac, Mellon, menstrual, mentioned, Merrimack, metastatic, Metastic, Milford, missing, mission, mistakenly, mL, MMN, MN, Mochida, modern, Modernization, Momenta, MSCI, mucosal, multi, multifactorial, multifocal, municipal, mutation, myeloma, nanoliposomal, NE, necessitating, Nektar, neuropathy, newborn, Newsweek, NOA, noninfringement, nose, notional, NovoEight, NSP, Nurse, Nuwiq, OBIZUR, obligor, OCI, oCIO, OCTAGAM, Octapharma, ONCASPAR, oncotic, ONIVYDE, ONIYDE, ONYVIDE, OPEB, OPKO, opt, organelle, Ornkov, overhead, oversupply, pacritnib, pancreatic, PANZYA, passionately, pathogenic, PBO, PDL, pegaspargase, pegol, pegylated, PEGylation, perioperative, perpetual, pharmacokinetic, PharmaEngine, Pharmstandard, PhaseRx, PhD, physician, PI, PID, Pierce, Piercetown, PLASBUMIN, polyradiculoneuropathy, pool, porcine, Prasco, prefilled, preserve, prime, PRIVIGEN, proactively, problem, proline, propensity, proposition, Proteinase, PROTHROMPLEX, PRV, pump, pure, purely, purified, purpura, Rahib, reactivated, readout, real, realigned, rebrand, reconstitution, redesignate, referendum, refractive, RegeneRx, REGENXBIO, regimen, Reinsurance, remarkable, remeasured, remitting, remote, renamed, repeal, rescheduled, respiratory, revalued, rEVO, revocation, rFVII, rFVIII, RI, rid, roll, room, roughly, ROW, RPD, rpFVIII, RS, RT, safer, SAIIDAC, salt, Sanofi, SCIG, Scrip, seldom, sensory, sequence, sequestration, SFJ, Shore, sicca, signatory, sliding, SOBI, solid, Southampton, span, SPECTRILA, spectrum, Spencer, square, Sterile, Sternberg, stinging, Stipulation, stood, Stratton, stripping, Stroucken, subcellular, SUBCUVIA, sudden, sum, suppressed, surgical, Symphogen, synergy, Taiho, tailored, Taiwanese, talk, tangible, TerraVia, Text, thousand, threatening, thrombocytopenic, thrombotic, Thyroid, timeline, title, titled, tofacitinib, tolling, Toronto, tracing, traditional, trajectory, trauma, travel, triennial, turnover, TV, tying, TYVANSE, unadjusted, unclear, uncollectible, unconditionally, understood, Underwriting, undesignated, undiagnosed, unreliability, unsecured, upadacitinib, upholding, ustekinumab, VA, vastly, Vermont, volixibat, von, VONVENDI, voucher, VUXEN, VWD, VWF, Walker, watching, wear, weighed, white, wholly, Wilate, Willebrand, Willibrand, windy, wrote, XIIDRA, yen, Zenaca
Removed:
Abbey, abdomen, add, addressed, adjunctive, agonist, allocate, ANVISA, Article, ascribed, Authorisation, baseline, Basingstoke, Beecham, binder, BioChem, Biology, blinding, Bowen, buyer, cancellation, capitalisation, capsule, CCR, CER, chelating, chelation, CIA, circumvention, CKD, clarification, clarify, collagen, computed, conclude, conclusion, conversion, convertible, cortex, creation, creditable, curve, Decentralised, dedicated, dependence, deterioration, devastating, deviate, Dial, Diego, diet, direction, distinct, draft, duty, EAIP, elevated, enrolled, faster, feet, Formulated, fuelled, Glaxo, GmbH, GSK, gut, honour, illustrate, improving, independently, individually, inhibiting, insured, investigated, iron, Italian, Jabil, judgement, KDIGO, LAMIVUDINE, lapsed, larynx, leverage, lining, lowering, materialize, mature, memory, mg, MICROTROL, minimise, Mitsui, monotherapy, Nephrol, nephropathy, ninety, noncurrent, novelty, Noven, Nyon, overload, paediatric, pair, palliative, patency, Pharmaceutica, phosphate, powder, predetermined, prefrontal, Premacure, PREMIPLEX, prioritized, pursue, randomized, ranging, recommend, recovered, Registrar, representation, residual, Salix, Santander, saved, scalable, screening, seller, separable, signalling, similarly, simple, situation, SmithKline, Spanish, split, stamp, Stout, streamlining, strongly, surveillance, symptom, Tanaud, transfusion, undrawn, uneconomic, unpredictable, untreated, unutilized, vendor, viability, viral, visual, voluntarily, VSOE, warranted, wealth, widespread, Yakuhin, Zug
Filing tables
Filing exhibits
Related press release
SHPG similar filings
Filing view
External links
EXHIBIT 23.1
Â
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements on Form S-8 (Nos. 333-09168, 333-60952, 333-91552, 333-111579, 333-129961, 333-129960, 333-202302, 333-175839, 333-165137, and 333-211941), Form S-3 (No. 333-213502) and Post-Effective Amendment No. 2 to the Registration Statement on Form S-4 (No. 333-209648) on Form S-3 of our reports dated February 22, 2017, relating to the consolidated financial statements and financial statement schedule of Shire plc and subsidiaries, and the effectiveness of Shire plc and subsidiaries’ internal control over financial reporting, appearing in this Annual Report on Form 10-K of Shire plc for the year ended December 31, 2016.
/s/ Deloitte LLP
London, United Kingdom
February 22, 2017